Industry Summit

Day 1 – Industry Summit

09:10
  • What are the learnings from the experiences of the technology sector in today’s cannabis industry?
  • Innovations’ role in overcoming stigma
  • Key drivers for growth and building trust in global markets
  • Sustainability is the key in driving the industry forward

Melissa Clark-Reynolds ONZM, Futurist

09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran Chief Executive Officer, Helius Therapeutics
Rob Mitchell Chief Executive Officer, Rua Bioscience
Mark Lucas Chief Executive Officer, Cannasouth
Tim Aldridge Managing Director, Puro
10:20
  • Medicinal cannabis licensing regime
  • Verification of products against the minimum quality standards
  • Regulation changes
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
11:20
Industry
  • A bigger picture view of the import and export industry in New Zealand
    • How has COVID impacted this industry and what are the trends we are seeing going forward?
    • How is this affecting New Zealand’s harvest?
    • What is the option for recovery as export plays a key role in New Zealand’s economy?
  • Discussing the pipeline for New Zealand’s medicinal cannabis industry to export homegrown products
  • Learnings from overseas that can be implemented for New Zealand
12:10
Industry

This panel showcases some key players in New Zealand’s primary industries and how they are harnessing their brand story and aligning it with New Zealand’s story. This panel will shed light on the value chain opportunity and how medicinal cannabis can follow suit.

  • Using New Zealand’s clean green image, in the local medicinal cannabis industry – how can we leverage this for our value chain?
  • Coming together and collaborating to advocate for the industry – what is the opportunity here?

13:40
Industry
  • A glimpse into the journey of bringing a product in the market
  • The challenges and barriers faced in making this a reality
  • Specific challenges tackling different regulatory systems around the world
  • Breaking barriers in product to market strategies – what are the learnings?
  • The way forward

Peter Crock Chief Executive Officer, Cann Group
14:20
Industry
  • Providing input into threats that harm New Zealand’s environment – how does this impact the growers in New Zealand?
  • A level playing field to provide parity in the primary industries

14:50
Industry
  • Setting a benchmark – how is the hemp sector paving the way for the primary industries sector to incorporate sustainable practices to create a smaller environmental footprint?
  • Discussing how hemp helps reduce pollution and environmental impact

16:00
  • The journey of medicinal cannabis – from seed to shelf – why this is and should be considered a medicine 
  • Working with the industry to educate on the benefits of medicinal cannabis 
  • Showcasing the evidence of the impact of medicinal cannabis in treating sickness
  • Combatting the misconception of addiction of medicinal cannabis in usage for treatment 
Dr Dave Hepburn Medical Advisor, CloudForest Peru
16:40
  • Providing an overview of AUS/NZ approach to growing cannabis for medicinal purposes
    • An in-depth discussion on indoor versus outdoor growth – how do they differ and will one dominate over the other?
  • Showcasing technology in play to capture data and assisting with cultivation
  • The road that lays ahead – opportunities for growth and collaboration
Tom Forrest Cultivation Director, Puro
09:10
  • What are the learnings from the experiences of the technology sector in today’s cannabis industry?
  • Innovations’ role in overcoming stigma
  • Key drivers for growth and building trust in global markets
  • Sustainability is the key in driving the industry forward

Melissa Clark-Reynolds ONZM, Futurist

09:50
  • Comparing New Zealand’s medicinal cannabis industry to the world
  • The opportunity to join the global industry and be amongst the global players
  • What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
  • What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
  • Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Carmen Doran Chief Executive Officer, Helius Therapeutics
Rob Mitchell Chief Executive Officer, Rua Bioscience
Mark Lucas Chief Executive Officer, Cannasouth
Tim Aldridge Managing Director, Puro
10:20
  • Medicinal cannabis licensing regime
  • Verification of products against the minimum quality standards
  • Regulation changes
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
11:20
Science
  • What are the trends we are seeing no cannabis Phyto-cannabinoids
  • Synthetics cannabinoids and their role in the development of new drugs
11:20
Science

• New Zealand gene bank
• different genetic technologies
• development of unique plants to those grown internationally
• Which traits to select- from disease resistance to cannabinoid profiles
• role of data management in a well-run breeding programme

13:40
Science
  • Highlighting the different services available in cannabis testing in New Zealand
    • How does New Zealand rank globally on testing?
  • Providing a global view – what are the trends we are seeing in cannabis testing around the world?
  • Any key learnings for New Zealand to implement?

 

14:20
Science
  • Making the business case for commercialising medicinal cannabis whilst adhering to the regulations – how can this be achieved effectively?
  •  Understanding methodological innovations required when undertaking Research on cannabis

Dr. Adele Hosseini, PhD Chief Scientific Officer, Bod Australia
14:50
Science
Dr Rachel Galettis Clinical Trial Manager, Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE)
16:00
  • The journey of medicinal cannabis – from seed to shelf – why this is and should be considered a medicine 
  • Working with the industry to educate on the benefits of medicinal cannabis 
  • Showcasing the evidence of the impact of medicinal cannabis in treating sickness
  • Combatting the misconception of addiction of medicinal cannabis in usage for treatment 
Dr Dave Hepburn Medical Advisor, CloudForest Peru
16:40
  • Providing an overview of AUS/NZ approach to growing cannabis for medicinal purposes
    • An in-depth discussion on indoor versus outdoor growth – how do they differ and will one dominate over the other?
  • Showcasing technology in play to capture data and assisting with cultivation
  • The road that lays ahead – opportunities for growth and collaboration
Tom Forrest Cultivation Director, Puro

Day 2 – Industry Summit

09:00

Addressing the challenges associated with accessing medicinal cannabis

09:30
  • Setting the scene – how medicinal cannabis is being used to heal illness?
  • Advocating for equity in access to medicinal cannabis for patients
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
10:40
  • The opportunity to develop the CBD sector in New Zealand – what are the resources available to achieve this?
  • Insights into the economic opportunity

11:10
  • Examining how medicinal cannabis can be a big contributing factor to NZ’s economy
  • Callaghan’s assistance in companies being established in the medicinal cannabis industry
  • Insights on how the roadmap has been developed and how it is evolving with the changing nature of regulations

11:40
  • Explaining the work currently being undertaken by Crown Research Institutes in the medicinal cannabis space
  • Advocating for the industry – a spotlight on the work taking place here

Dr Trevor Stuthridge Research Director, AgResearch
Dr Stefan Hill Portfolio Leader for High-Value Biorefineries, Scion
Dr Richard Newcomb, PhD Chief Scientist, Plant & Food Research
13:10
  • Exploring the reality of using CBD oil and other CBD products for animals
  • Educating the people on the use of medicinal cannabis use for animals – how can this be done effectively?
  • Insights on how medicinal cannabis is used in conjunction with other medicines for pets
  • Highlighting overseas success stories that New Zealand can learn and benefit from

Jacob Morrison, VetCanNZ

13:40
  • The impact and opportunity that disruptive technology has on New Zealand’s primary industry
  • Becoming a data focused cultivator with the use of AI and ML – how can growers make informed decisions using this?
  • Segmenting critical information to capture growth patterns

14:40
Katy Thomas TV Presenter. Editor. Mother And Overnight Influencer
15:20

Martin Lee, Director, Project CBD

10:40
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
10:40
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
10:40
  • Nutrients
  • Grow media
  • Bio pesticides
10:40

What are considerations for the sector?

10:40

What are considerations for the sector?

13:10
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:10
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
13:10
  • Nutrients
  • Grow media
  • Bio pesticides
13:10

What are considerations for the sector?

13:10

What are considerations for the sector?